Biocon Biologics to Acquire Viatris' (VTRS) Biosimilars Assets for up to $3.335 billion in Stock and Cash

Go back to Biocon Biologics to Acquire Viatris' (VTRS) Biosimilars Assets for up to $3.335 billion in Stock and Cash
(NASDAQ: VTRS) Delayed: 16.88 -0.06 (0.35%)
Previous Close $16.94    52 Week High
Open $16.81    52 Week Low
Day High $17.02    P/E N/A 
Day Low $16.67    EPS
Volume 5,732,791